Free Trial
LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

Dr. Martens logo
GBX 83.80 +1.20 (+1.45%)
As of 07/25/2025 11:50 AM Eastern

About Dr. Martens Stock (LON:DOCS)

Key Stats

Today's Range
80.55
85.41
50-Day Range
54.70
83.80
52-Week Range
43.02
85.41
Volume
1.48 million shs
Average Volume
2.07 million shs
Market Capitalization
£813.50 million
P/E Ratio
11.88
Dividend Yield
3.58%
Price Target
GBX 6,000
Consensus Rating
Hold

Company Overview

Dr. Martens Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

DOCS MarketRank™: 

Dr. Martens scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Dr. Martens has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Dr. Martens has only been the subject of 2 research reports in the past 90 days.

  • Read more about Dr. Martens' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dr. Martens is 11.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.01.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dr. Martens is 11.88, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 70.70.

  • Price to Earnings Growth Ratio

    Dr. Martens has a PEG Ratio of 6.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Dr. Martens has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for DOCS.
  • Dividend Yield

    Dr. Martens pays a meaningful dividend of 1.36%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Dr. Martens does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Dr. Martens is 42.53%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Dr. Martens' dividend.
  • Short Interest

    There is no current short interest data available for DOCS.
  • News Sentiment

    Dr. Martens has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Consumer Cyclical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Dr. Martens this week, compared to 2 articles on an average week.
  • Search Interest

    Only 12 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £597.38 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 4.36% of the stock of Dr. Martens is held by insiders.

  • Percentage Held by Institutions

    69.53% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Dr. Martens' insider trading history.
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Dr. Martens' stock was trading at GBX 72.20 at the start of the year. Since then, DOCS shares have increased by 16.1% and is now trading at GBX 83.80.

Dr. Martens plc (LON:DOCS) announced its quarterly earnings results on Thursday, June, 5th. The company reported $2.40 EPS for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%.
Read the conference call transcript
.

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY).

Company Calendar

Last Earnings
6/05/2025
Today
7/26/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Footwear & Accessories
Sub-Industry
Computer Software
Current Symbol
LON:DOCS
CIK
N/A
Fax
N/A
Employees
890
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 6,000
Low Price Target
GBX 6,000
Potential Upside/Downside
+7,059.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 7.05
Trailing P/E Ratio
11.88
Forward P/E Ratio
32.47
P/E Growth
6.4
Net Income
£68.97 million
Net Margins
7.89%
Pretax Margin
N/A
Return on Equity
18.91%
Return on Assets
8.12%

Debt

Debt-to-Equity Ratio
127.27
Current Ratio
2.85
Quick Ratio
1.13

Sales & Book Value

Annual Sales
£874.20 million
Price / Sales
0.93
Cash Flow
GBX 5.87 per share
Price / Cash Flow
14.29
Book Value
GBX 37.80 per share
Price / Book
2.22

Miscellaneous

Outstanding Shares
970,763,405
Free Float
N/A
Market Cap
£813.50 million
Optionable
Not Optionable
Beta
0.11
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:DOCS) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners